Prostate Cancer

Medical and scientific communities continue to weigh the value of PSA screening

BRCA mutations can lead to prostate and other cancers, and men are as likely as women to inherit them. Yet male awareness is lagging.

Whether to opt for surgery or radiation to treat localized prostate cancer depends mainly on the stage and grade of disease.

New drug treatments are helping patients with advanced prostate cancer to live longer.

Innovative approaches offer more surgical options with potentially fewer side effects.

Sexual activity after prostate cancer therapy might be different, but still possible.

New ways to find prostate cancer and gauge its aggressiveness help patients make better choices.

Leslie R. Schover, professor of behavioral science, The University of Texas MD Anderson Cancer Center, discusses information and education for patients regarding sexuality after treatment.

Leslie R. Schover, professor of behavioral science, The University of Texas MD Anderson Cancer Center, discusses some problems men face after cancer treatment.

New diagnoses of prostate cancer have declined nearly 30 percent, a study has found, since the U.S. Preventive Services Task Force discouraged the routine use of prostate-specific antigen testing in 2011.